Masaya Koshizaka

37PUBLICATIONS
53CO-AUTHORS
HaematologyPharmacogenomicsEpidemiological modellingOptical technologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Aug 18, 2026
Baseline HDL Cholesterol and the Anti-VEGF Injection-Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial.

|Aug 12, 2026
Association of GLP-1 Receptor Agonist Use With Cardiovascular Outcomes and Mortality in Japanese Patients With Type 2 Diabetes: A Real-World Claims Database Study.

|May 06, 2026
Sodium-glucose cotransporter 2 inhibition and injection burden in mild diabetic macular edema: An exploratory post hoc analysis of the COMET trial.

|May 03, 2026
Ophthalmic Backgrounds Influencing the Efficacy of SGLT2 Inhibitor in Diabetic Macular Oedema: Post-hoc Analysis of the COMET Trial.

|Dec 19, 2025
Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial.

Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna

|Sep 09, 2025
Emerging strategies, applications and challenges of targeting NAD+ in the clinic.

Jianying Zhang, He-Ling Wang, Sofie Lautrup

Pageof 7

Frequent Collaborators

13 joint publications

Minoru Takemoto

11 joint publications

Koutaro Yokote

11 joint publications

Ryoichi Ishibashi

10 joint publications

Hironori Nakagami